Ventana Medical Systems, Inc. is recalling approximately 22,839 kits of the Ventana anti-CD10 (SP67) Rabbit Monoclonal Primary Antibody. The recall was initiated because the product may cause high background and off-target staining during laboratory testing. This defect can lead to false positive results, meaning a test might incorrectly indicate the presence of a condition or substance when it is not actually there. These antibodies are primarily used in clinical laboratories and medical diagnostic settings.
The potential for high background and off-target staining significantly increases the risk of false positive diagnostic results. This can lead to incorrect medical diagnoses, potentially causing patients to receive unnecessary or inappropriate treatments based on flawed laboratory data.
Manufacturer notification via letter
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.